Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol.
D058891:5-alpha Reductase Inhibitors; D000368:Aged; D000736:Androstenes / Q000627:therapeutic use*; D001378:Azasteroids / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004958:Estradiol / Q000097:blood* / Q000378:metabolism; D018120:Finasteride; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood* / Q000378:metabolism; D008297:Male; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000097:blood* / Q000188:drug therapy*
D058891:5-alpha Reductase Inhibitors; D000736:Androstenes; D001378:Azasteroids; D004958:Estradiol; D018120:Finasteride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone